The Role of Spreader Grafts in Reduction Septorhinoplasty: A Randomized Clinical Trial With Quality of Life Assessment
The Laryngoscope · 2025
DOI: 10.1002/lary.32131 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Laryngoscope, 2025. Verfasst von Raphaella Migliavacca und 5 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pneumological Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Rhinoplasty, Quality of Life, Nasal Septum, Nasal Obstruction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Hospital deClínicas de Porto Alegre (HCPA) Research and Events Incentive Fund (FIPE/HCPA), Hospital de Clínicas de Porto Alegre.
Abstract (Originalsprache)
Objective
To evaluate the impact of spreader grafts in reduction septorhinoplasty on quality of life (QOL) outcomes. Trial Design Randomized clinical trial (RCT).
Methods
Individuals over 15 years old with nasal obstruction were evaluated for functional and aesthetic septorhinoplasty from October 2018 to October 2022 at a facial plastic surgery clinic of a tertiary university hospital in Brazil. Participants were randomly allocated to subjects with or without spreader grafts. Primary outcome: Relative changes in specific Nasal Obstruction Symptom Evaluation in the Portuguese language (NOSE‐p). Outcomes were assessed at least 6 and 12 months postoperatively (PO ≥ 6 and PO ≥ 12 m). The participants and those assessing the outcomes were blinded to group assignment.
Results
A 50 patients were included, 25 randomized to each group, mainly Caucasians with moderate/severe allergic rhinitis symptoms. Mean age was 32.89 ± 13.36 years and 68% were female. Septorhinoplasty improved specific quality‐of‐life scores irrespective of using spreader grafts ( p < 0.001). There was no difference between subjects submitted or not to placement of spreader grafts in NOSE‐p score in PO ≥ 6 m (−60.0 vs. −66.6%; p = 0.37); ROE in PO ≥ 6 m (71.83 vs. 79.56; p = 0.35), NO‐VAS in PO ≥ 6 m (13.00 vs. 8.00; p = 0,35), NOSE p in PO ≥ 12 m (−53.14% vs. −68.33%; p = 0.28), ROE in PO ≥ 12 m (76.33 vs. 79.53; p = 0.645), NO‐VAS in PO ≥ 12 m (13.00 vs. 11.50; p = 0.60).
Conclusions
Reduction septorhinoplasty was associated with improvement in quality of life regarding nasal obstruction irrespective of using spreader grafts in a 7.88‐month follow‐up. Level of Evidence 2. Trial Registration: ClinicalTrials.gov identifier: (NCT0449946).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduate Program in Pneumological Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Otorhinolaryngology and Head and Neck Surgery Department, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
- School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
ORCID-Profile: Eduardo Priesnitz Friedrich
Förderung
- Hospital deClínicas de Porto Alegre (HCPA) Research and Events Incentive Fund (FIPE/HCPA)
- Hospital de Clínicas de Porto Alegre
Zitieren
APA
Migliavacca, R., Lavinsky, M., Friedrich, E. P., de Freitas Toledo, S. A., de Azeredo, A. M., & Silva, D. R. (2025). The Role of Spreader Grafts in Reduction Septorhinoplasty: A Randomized Clinical Trial With Quality of Life Assessment. The Laryngoscope. https://doi.org/10.1002/lary.32131
Vancouver
Migliavacca R, Lavinsky M, Friedrich EP, de Freitas Toledo SA, de Azeredo AM, Silva DR. The Role of Spreader Grafts in Reduction Septorhinoplasty: A Randomized Clinical Trial With Quality of Life Assessment. The Laryngoscope. 2025. doi:10.1002/lary.32131
BibTeX
@article{Migliavacca2025,
author = {Migliavacca, Raphaella and Lavinsky, Michelle and Friedrich, Eduardo Priesnitz and de Freitas Toledo, Samuel Afonso and de Azeredo, Andreza Mariane and Silva, Denise Rossato},
title = {The Role of Spreader Grafts in Reduction Septorhinoplasty: A Randomized Clinical Trial With Quality of Life Assessment},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32131}
}
EUVIMED